User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

4227

Interactions with Platform & by Email *

INTERACTIONS

761

Unique # Participated *

PARTICIPANTS

127

Responses Validated *

VALIDATIONS

37

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
Definitions.....I-3
Polymerase Chain Reaction.....I-3
Other Gene Amplification Technologies.....I-3
  
   PCR Dominates Amplification Technologies.....II-1
Growth Prospects Live in PCR Market despite Competition.....II-1
Miniaturization – The Next Big Focus.....II-1
1$100
   Critical in Diagnostic Procedures.....II-2
Leading Players.....II-2
1$100
   Definition of Gene Amplification.....II-3
Target vs. Signal Amplification.....II-3
Available Types of Gene Amplification Technologies.....II-3
Polymerase Chain Reaction.....II-3
1$100
   Reagents and Equipment required for PCR.....II-4
Reaction Steps.....II-4
Denaturation.....II-4
Annealing.....II-4
Extension.....II-4
1$100
   Detection of Amplified Product/DNA.....II-5
(Q&Q) PCR.....II-5
Reverse Transcriptase PCR (RT-PCR).....II-5
1$100
   Alternative Technologies to PCR.....II-6
OmniPlex.....II-6
Strand Displacement Amplification.....II-6
1$100
   Ligase Chain Reaction.....II-7
LCR Involves a Cyclic Two-Step Reaction.....II-7
Gene Amplification Technology (GAT).....II-7
Hybrid Capture.....II-7
Isothermal DNA Amplification Techniques.....II-7
Rolling circle Amplification in Diagnostics.....II-7
1$100
   Ican Isothermal Gene Amplification Technology.....II-8
BioHelix HDA Technology.....II-8
Other Amplification Technologies.....II-8
Signal Amplification Technology.....II-8
Transcription Mediated Amplification.....II-8
1$100
   DNA cleavage-based signal amplification.....II-9
Ramification Amplification Method.....II-9
1$100
   Medical and Diagnostics.....II-10
Role of Amplification Technology in the Diagnoses of Infectious Diseases.....II-10
Diagnosis of Infectious Diseases by PCR.....II-10
1$100
   Detection of Antimicrobial Resistance.....II-11
PCR Based Nucleic Acid Amplification for Detection of Antimicrobial Agents.....II-11
Nucleic Acid Amplification Testing (NAT).....II-11
1$100
   Nucleic Acid Amplification Methods.....II-12
DNA Amplification Technology in the Diagnosis of Infectious Diseases.....II-12
Forensic and Paternity Testing.....II-12
1$100
   Food Safety.....II-131$100
   DuPont Qualicon Launches New BAX® System Real-Time PCR Assay.....II-14
Rubicon Genomics Launches PicoPlex Single Cell WGA Kit.....II-14
NuGEN Unveils WT-OvationTM RNA Amplification System for Whole-Transcriptome Gene
  Expression Analysis.....II-14
1$100
   DuPont Qualicon Obtains Approval from Russian Federal Consumer Rights Protection and
  Human Health Control Service for BAX™ System.....II-15
DuPont Qualicon Receives Approval from the General Administration of Quality
  Supervision, Inspection and Quarantine for BAX® system.....II-15
1$100
   Seegene Enters into Partnership with Shimadzu.....II-16
Bio-Rad Launches New CFX96 PCR Detection System.....II-16
1$100
   Roche Introduces Genome Sequencer FLX System.....II-17
QIAGEN Launches TopTaq DNA Polymerase.....II-17
Applied Biosystems Introduces TaqMan Array Human MicroRNA Panel.....II-17
1$100
   Spartan Introduces Spartan DX.....II-18
Applied Biosystems Launches Forensic Tools.....II-18
Applied Biosystems Introduces StepOne Real-Time PCR System.....II-18
1$100
   Sigma-Aldrich Unveils GenomePlex Tissue Whole Genome Amplification Kit.....II-19
QIAGEN Rolls Out Wide RNAi and SYBR® Green-based RT- PCR.....II-19
Applied Biosystems Launches 7500 Fast Real-Time PCR System.....II-19
Applied Biosystems Launches 9800 Fast PCR System.....II-19
1$100
   7900HT Fast Real-Time PCR System from Applied Biosystems.....II-20
Enzo Life Sciences Introduces New Advanced Amplification Technology.....II-20
Applied Biosystems Unveils AmpFSTR® Yfiler™ PCR Amplification Kit.....II-20
Amersham Launches GenomiPhi.....II-20
1$100
   Rubicon Genomics Launches GenomePlex WGA.....II-21
Agilent Introduces Amplification Kit.....II-21
Linden Introduces Snapshot mRNA.....II-21
Rubicon Launches OmniPlex™.....II-21
1$100
   QIAGEN Acquires Rights to 70 Molecular Food Safety Tests from ifp.....II-22
Life Technologies to Acquire Geneart.....II-22
Thermo Fisher Scientific Takes Over Finnzymes.....II-22
Abbott Inks Agreement with GlaxoSmithKline for Developing Molecular Diagnostic
  Test.....II-22
1$100
   DXS Purchases License for P13K Gene from Johns Hopkins University.....II-23
Qiagen Acquires SABiosciences.....II-23
DuPont Qualicon Obtains License from DxS for Scorpions® Technology.....II-23
BD Takes Over HandyLab.....II-23
1$100
   Life Technologies Takes Over BioTrove.....II-24
Merck Merges with Schering-Plough.....II-24
QIAGEN Acquires Licenses from Idaho Technology and Roche.....II-24
1$100
   Response Genetics Inks Non-Exclusive Agreement with Roche Diagnostics.....II-25
Invitrogen Announces Merger with Applied Biosystems.....II-25
Hologic Acquires Third Wave Technologies.....II-25
BIOTECON Acquires Roche's Technology License.....II-25
QIAGEN Signs a Global Licensing Agreement with BioHelix.....II-25
1$100
   BioTrove and Gene Express Receive NIH Grant for Innovative Bio-experimentation.....II-261$100
   SuperArray Bioscience Inks License Agreement with Applied Biosystems.....II-27
Merck Capital Takes Over Minority Interest in High Throughput Genomics.....II-27
NuGEN Enters into a Service Agreement with ExonHit.....II-27
Qiagen Enters into License Agreements with Roche and Ortho-Clinical.....II-27
1$100
   Agilent Takes Over Stratagene.....II-28
Eiken Chemical Inks Licensing Agreement with Meridian Bioscience.....II-28
Sigma-Aldrich Acquires JRH.....II-28
1$100
   Sigma-Aldrich Snaps Up Proligo.....II-29
Beckman Acquires Agencourt.....II-29
Roche Diagnostics and Applera Corporation Expand PCR Licensing Program.....II-29
Mount and Hamilton Receive Patent.....II-29
Invitrogen Bags License from Applied Biosystems.....II-29
OriGene to Access TrueClone.....II-29
Orchid BioSciences to Turn into Orchid Cellmark.....II-29
1$100
   QIAGEN Purchases Assets of Molecular Staging.....II-30
Cepheid, Applied Biosystems and Celera Diagnostics Sign Patent License
  Agreement.....II-30
Abbott Enters into Agreement with BioGenex.....II-30
Roche Inks Licensing Agreement with Incyte Corp.....II-30
1$100
   Rubicon Genomics Signs Licensing Agreement with Sigma-Aldrich.....II-31
BioMérieux Teams-up with Cepheid.....II-31
Molecular Staging Collaborates with Eli Lilly.....II-31
Pacific Biometrics Inc. Receives Gene Amplification Patent.....II-31
Rubicon Introduces Service for Genome Amplification.....II-31
Takara Obtains Patent for New Amplification Method.....II-31
1$100
   Abbott Laboratories (US).....II-32
Becton, Dickinson and Company (US).....II-32
bioMérieux (France).....II-32
1$100
   Bio-Rad Laboratories (US).....II-33
Cepheid (US).....II-33
Life Technologies Corp. (US).....II-33
1$100
   QIAGEN N.V. (The Netherlands).....II-34
Roche Diagnostics (Switzerland).....II-34
Rubicon Genomics (US).....II-34
1$100
   Takara Bio, Inc......II-351$100
   Table 1: World Recent Past, Current & Future Market Analysis for Gene Amplification Technologies by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-361$350
   Table 2: World Historic Review for Gene Amplification Technologies by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-371$350
   Table 3: World 15-Year Perspective for Gene Amplification Technologies by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-381$350
   Table 4: World Recent Past, Current & Future Market Analysis for Polymerase Chain Reaction (PCR) by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-391$350
   Table 5: World Historic Review for Polymerase Chain Reaction (PCR) by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-401$350
   Table 6: World 15-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-411$350
   Table 7: World Recent Past, Current & Future Market Analysis for Other Gene Amplification Technologies by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-421$350
   Table 8: World Historic Review for Other Gene Amplification Technologies by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-431$350
   Table 9: World 15-Year Perspective for Other Gene Amplification Technologies by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart).....II-441$350
   A. Market Analysis.....III-1
Real-Time PCR Market in North America: A Primer.....III-1
Table 10: Leading Suppliers of Individual qPCR Reagents in North America (2008): Percentage Dollar Share Breakdown of Invitrogen, Applied Biosystems, Roche Applied, Bio-Rad/ MJ, BD Clontech, Promega, Amblon, NEB, Qiagen, and Others (includes corresponding Graph/Chart).....III-1
1$200
   Key Factors (Ranked in Order) in Selection of Real-Time/qPCR Platforms
  Manufacturers.....III-2
Top 10 Research Applications of Real-Time Quantitative PCR (qPCR) in North
  America.....III-2
1$75
   B. Market Analytics.....III-3
Table 11: US Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-3
1$200
   Table 12: US Historic Review for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-41$200
   Table 13: US 15-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-51$200
   Market Analysis.....III-6
Table 14: Canadian Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-6
1$200
   Table 15: Canadian Historic Review for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-71$200
   Table 16: Canadian 15-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-81$200
   Market Analysis.....III-9
Table 17: Japanese Recent Past, Current & Future nalysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-9
1$200
   Table 18: Japanese Historic Review for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-101$200
   Table 19: Japanese 15-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-111$200
   Market Analysis.....III-12
Table 20: European Recent Past, Current & Future Analysis for Gene Amplification Technologies by Geographic Region – France, Germany, UK, Italy, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-12
1$200
   Table 21: European Historic Review for Gene Amplification Technologies by Geographic Region – France, Germany, UK, Italy, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-131$200
   Table 22: European 15-Year Perspective for Gene Amplification Technologies by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, & Rest of Europe Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-141$200
   Table 23: European Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-151$200
   Table 24: European Historic Review for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-161$200
   Table 25: European 15-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-171$200
   Market Analysis.....III-18
Table 26: French Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-18
1$200
   Table 27: French Historic Review for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-191$200
   Table 28: French 15-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-201$200
   Market Analysis.....III-21
Table 29: German Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-21
1$200
   Table 30: German Historic Review for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-221$200
   Table 31: German 15-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-231$200
   Market Analysis.....III-24
Table 32: Italian Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-24
1$200
   Table 33: Italian Historic Review for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-251$200
   Table 34: Italian 15-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-261$200
   Market Analysis.....III-27
Table 35: UK Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-27
1$200
   Table 36: UK Historic Review for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-281$200
   Table 37: UK 15-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-291$200
   Market Analysis.....III-30
Table 38: Rest of Europe Market for Gene Amplification Technologies - Recent Past, Current & Future Market Analysis by Segment for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-30
1$200
   Table 39: Rest of Europe Historic Review for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-311$200
   Table 40: Rest of Europe 15-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-321$200
   Market Analysis.....III-33
Table 41: Rest of World Market for Gene Amplification Technologies - Recent Past, Current & Future Market Analysis by Segment for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-33
1$200
   Table 42: Rest of World Historic Review for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-341$200
   Table 43: Rest of World 15-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-351$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com